Marie-Paul Lachaud
No más puestos en curso
Historial de carrera de Marie-Paul Lachaud
Antiguos cargos conocidos de Marie-Paul Lachaud.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ARATANA THERAPEUTICS INC | Corporate Officer/Principal | 26/03/2013 | - |
Formación de Marie-Paul Lachaud.
| École Nationale Vétérinaire d'Alfort | Undergraduate Degree |
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Estadísticas
Internacional
| Francia | 3 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
- Bolsa de valores
- Insiders
- Marie-Paul Lachaud
- Experiencia
